Placebo News and Research

RSS

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

17 Sep 2024

Study highlights limited evidence for antidepressants in treating pain in older adults

University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence.

16 Sep 2024

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found 'promising' antitumor activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian and endometrial cancers.

16 Sep 2024

Long-term benefits of immunotherapy highlighted in advanced melanoma and other cancers

Immunotherapy, which works by enabling the body's immune system to recognize and destroy cancer cells improves long-term overall survival in patients with advanced melanoma in results from large international studies reported at ESMO 2024.

16 Sep 2024

Hormone therapy found to improve insulin sensitivity in menopausal women

Menopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential benefits of hormone therapy on insulin resistance have produced mixed results.

16 Sep 2024

Combination treatment improves symptoms of agitated delirium in end-of-life cancer patients

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

16 Sep 2024

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

14 Sep 2024

Scientists develop selective therapy for tau tangles

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

14 Sep 2024

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Women experience greater weight loss with tirzepatide compared to men

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

11 Sep 2024

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

Molnupiravir treatment for COVID-19 shows modest long-term benefits, reducing symptoms and improving well-being at three and six months. However, the differences were small, with no impact on hospitalization rates.

11 Sep 2024

New study links gut bacteria to thiamine's role in reducing fatigue in IBD patients

Researchers explore the frequency of symptoms like chronic fatigue in IBD in relation to specific bacteria in the human gut.

11 Sep 2024

New study explores the potential of hormone therapy for opioid recovery

In the midst of America's growing opioid crisis, a much healthier alternative to long-term pain management is emerging - one affectionately known as "the cuddle hormone," or oxytocin.

11 Sep 2024

Obesity medication liraglutide safe and effective in children under 12, research finds

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of Medicine (NEJM), has found.

10 Sep 2024

Once-a-day oral weight loss drug shows promising results in reducing body weight

Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) will hear.

10 Sep 2024

Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

10 Sep 2024

Estrogen-based hormone therapies have favorable long-term effects on heart disease risk

Recent studies show that women can experience bothersome menopause symptoms, like hot flashes, for longer than originally estimated.

10 Sep 2024

Study finds clinical hypnosis more effective than cognitive behavioral therapy for hot flashes

Nonhormone options for hot flashes and other menopause symptoms are growing in popularity, especially for women who cannot take hormones due to health complications. Cognitive behavioral therapy and clinical hypnosis are common nonhormone treatment options.

10 Sep 2024

Best ways to quit smoking: E-cigs, medications, and counseling proven effective in new Cochrane analysis

Recent Cochrane reviews highlight effective smoking cessation interventions, revealing gaps in research and the need for improved tobacco addiction strategies.

9 Sep 2024

Placebo News and Research

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Study highlights limited evidence for antidepressants in treating pain in older adults

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Long-term benefits of immunotherapy highlighted in advanced melanoma and other cancers

Hormone therapy found to improve insulin sensitivity in menopausal women

Combination treatment improves symptoms of agitated delirium in end-of-life cancer patients

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

Scientists develop selective therapy for tau tangles

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Women experience greater weight loss with tirzepatide compared to men

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

New study links gut bacteria to thiamine's role in reducing fatigue in IBD patients

New study explores the potential of hormone therapy for opioid recovery

Obesity medication liraglutide safe and effective in children under 12, research finds

Once-a-day oral weight loss drug shows promising results in reducing body weight

Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Estrogen-based hormone therapies have favorable long-term effects on heart disease risk

Study finds clinical hypnosis more effective than cognitive behavioral therapy for hot flashes

Best ways to quit smoking: E-cigs, medications, and counseling proven effective in new Cochrane analysis

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News